Efficacy and Safety of a Simplified Lamivudine Plus Dolutegravir Dual Therapy in HIV-1-Infected Patients: A Multicenter Cohort Study in China: Erratum. . J Acquir Immune Defic Syndr 2022;91:516.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Efficacy and Safety of a Simplified Lamivudine Plus Dolutegravir Dual Therapy in HIV-1-Infected Patients: A Multicenter Cohort Study in China: Erratum. J Acquir Immune Defic Syndr 2022;91:516.
PMID: 36350800